title: Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro.
abstract: A comparative study in vivo of amodiaquine efficacy (35 mg/kg over 3 d) and chloroquine (25 mg/kg over 3 d) was conducted in 1991 and 1992 in Cameroon and Congo in 123 patients with uncomplicated Plasmodium falciparum malaria. Amodiaquine was more effective than chloroquine, with parasite clearance by day 7 in 79.7% of the patients compared with 59.4%. Sixteen of 32 (50%) P. falciparum isolates tested in vitro were resistant to chloroquine and only 3 of 34 (9%) were resistant to amodiaquine. 5.3% of patients treated with amodiaquine complained of pruritus and 18.7% of nausea, compared with 15.7% and 5% respectively of those treated with chloroquine.
authors.affiliation: Laboratoire de Parasitologie, Centre Hospitalier Universitaire, Rouen, France.
authors.forename: P
authors.initials: P
authors.lastname: Brasseur
authors.forename: P
authors.initials: P
authors.lastname: Agnamey
authors.forename: A S
authors.initials: AS
authors.lastname: Ekobo
authors.forename: G
authors.initials: G
authors.lastname: Samba
authors.forename: L
authors.initials: L
authors.lastname: Favennec
authors.forename: J
authors.initials: J
authors.lastname: Kouamouo
mesh_terms: D000293:Adolescent; D000328:Adult; D000655:Amodiaquine / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D002163:Cameroon; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000009:adverse effects / Q000627:therapeutic use*; D003223:Congo; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007223:Infant; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010963:Plasmodium falciparum / Q000187:drug effects; D011537:Pruritus / Q000139:chemically induced
chemical_list: D000962:Antimalarials; D000655:Amodiaquine; D002738:Chloroquine